Serious Safety Risks Prescribing information for GLP-1 medications includes warnings related to: Thyroid C-cell tumors observed in animal studies Pancreatitis Gallbladder disease Kidney-related complications Adherence and Real-World Effectiveness Experts note that results seen in clinical trials may differ from real-world outcomes
Taken together, preclinical models of PD demonstrate the promising neuroprotective potential for GLP-1 receptor agonists to reduce inflammation and -synuclein accumulation, whilst restoring mitochondrial function and motor deficits
GHK-CU peptide therapy complements hormone optimization by supporting tissue repair, cellular signaling, and structural integrity
Whether that matters clinically is still debated, but for people with arrhythmias or other heart conditions it's worth a second look
Contact your healthcare provider immediately if you experience severe muscle pain with dark urine, signs of dehydration such as dizziness or decreased urination, persistent gastrointestinal symptoms, or any unexplained severe weakness or fatigue
Sato T, Machida T, Takahashi S, Iyama S, Sato Y, Kuribayashi K et al